TCR2 Therapeutics  logo
TCR2 Therapeutics TCRR
$ 1.48 0.0%

Quarterly report 2023-Q1
added 05-11-2023

report update icon

TCR2 Therapeutics Cash Flow 2011-2024 | TCRR

Annual Cash Flow TCR2 Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-101 M -81.6 M -56.7 M -41.4 M -18.7 M - - - - - - -

Depreciation & Amortization

3.05 M 2.83 M 1.59 M 862 K 419 K - - - - - - -

Accounts Payables

2.79 M 2.14 M 2.45 M 2.48 M - - - - - - - -

Accounts Receivables

- - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow TCR2 Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

-40 M - -76.5 M -50.7 M -31.1 M - -58.3 M -38.9 M -23.9 M - -43.2 M -32.4 M -16.4 M - -31 M -21 M -10.8 M - -12.3 M -7.69 M -3.01 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

615 K - 2.3 M 1.41 M 706 K - 1.98 M 1.2 M 513 K - 1.11 M 673 K 306 K - 558 K 300 K 135 K - 303 K 188 K 76 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

6.32 M 2.79 M 2.96 M 5.47 M 4.48 M 2.14 M 4.38 M 4.82 M 3.83 M 2.45 M 2.45 M 2.45 M 2.45 M 2.48 M 2.48 M 2.48 M 2.48 M 2.66 M 2.66 M 2.66 M 2.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency